Website update in progress

Following the transformation of Polpharma Biologics (learn more), this site will focus on biosimilars development in Switzerland. In Poland, we operate now as Rezon Bio – a contract developer and manufacturer of biologics (CDMO). More at www.rezonbio.com.
Due to the demerger of Polpharma Biologics into two independent companies (detailed information can be found in the “Knowledge center” section), the website polpharmabiologics.com is currently being updated. For details on the CDMO business, please visit the Rezon Bio website

Informacja o realizowanej strategii podatkowej za 2023 rok

Polpharma Biologics S.A. jest zobowiązana do sporządzenia i opublikowania informacji o realizowanej strategii podatkowej w celu wykonania obowiązku określonego w art. 27c ust. 1 w związku z art. 27b ust. 2 pkt 1 i 2 Ustawy z dnia 15 lutego 1992 r. o podatku dochodowym od osób prawnych. Zapraszamy do zapoznania się z dokumentem.

Code of conduct

This Code of Conduct is the first step to showing dedication to upholding continuous excellence in both business and ethical terms, and showing our care and dedication to products, clients and success.